UAlberta receives $2.85M to create ALS research platform

August 19, 2021
The University of Alberta has received $2.85M from Brain Canada to create a platform to support ALS research. The platform – titled Comprehensive Analysis Platform to Understand, Remedy, and Eliminate ALS (CAPTURE ALS) – will gather patients’ biological data such as blood and cerebrospinal fluids, which can be used by researchers to guide more personalized treatment. CAPTURE ALS will also expand work being done by the Canadian ALS Neuroimaging Consortium (CALSNIC) to develop and validate biomarkers to use in the tracking and treatment of ALS. “The harmonization of standard operating procedures across all sites is important, so there can be uniformly high-quality data and materials,” said UAlberta team lead Sanjay Kalra. “Then, all of this will be available to researchers globally.” UAlberta (AB)